Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
abdomen, abuse, Accredo, Affordable, Alexion, Amersham, AMP, analytical, angina, apportioned, arm, art, ascribed, Austria, Becton, billion, Bio, biomedical, BioScrip, biosimilar, Biosimilarity, Boehringer, border, BPCIA, Brewery, budget, children, civil, CMS, cold, constrain, constraint, contraindicated, convenience, copied, Coram, CV, DC, Department, depth, Dickinson, dictate, dispensed, dispensing, dispose, donut, draft, Experimental, family, flu, fraud, gap, Glenn, GmbH, greatest, hand, headache, hole, home, Hong, Hospira, HPT, implicit, imposition, inactive, indirect, infarction, Ingelheim, ingredient, inter, interchangeable, intervention, justified, Kong, Lee, licensure, lifelong, Macau, Malaysia, mandatory, marketvalue, Maryland, Melrose, menopausal, mission, mobilization, myocardial, network, NIH, nondeductible, notwithstanding, Obama, outpatient, overload, oversee, pen, penetrate, peripheral, perpetual, pharmacy, Piamjariyakul, pioneering, poor, potency, PPACA, pre, pressure, principle, proven, purity, reaction, rebate, reexamination, refinancing, reincorporated, retail, retroactive, Rockhurst, Room, root, route, scientist, scrutiny, shipped, Singapore, skin, solid, statutory, stomach, Street, strength, strong, sublicense, sublicensed, substituted, survey, suspension, swelling, synco, teaching, ThriveRx, toxicity, transform, transparency, Unallocated, unclear, unstable, vascular, Vetter, viewed, warehouse, warning
Removed:
adaptive, adjunct, administered, alleging, allocate, analyst, approach, ApS, architecture, AstraZeneca, atrophy, attention, benign, birth, building, capture, carcinogenicity, carryback, CDAI, chemistry, chemotherapy, cohort, compare, competent, composition, consulting, conventionally, Cottrell, counseled, Danmark, DDW, deconsolidated, desegregation, Digestive, dispute, distal, district, DNA, dosing, dysmotility, Eastern, efficient, EITF, endoscopic, enroll, enrolled, enrollment, epithelial, epithelium, fifty, forward, franchise, fully, gained, Gastroenterology, glutamine, gut, hepatic, hired, imbalance, immature, Importantly, induced, infrastructure, INO, integrity, interference, Jeppesen, journalGut, Labor, lecturer, letter, liter, MA, malignant, maturation, Medicademy, MHLW, micronutrient, minimize, Ministry, morbidity, multiple, naturally, Nordisk, Novo, nutrition, objective, obstruction, optimize, panel, participating, Pennsylvania, pharmacological, PhD, PMDA, PN, preterm, professor, prospectively, rat, raw, reallocate, reallocated, reallocation, redeemed, refocusing, remained, remodeled, responded, response, restore, restored, restoring, restructured, retained, RNA, Sandra, score, secreted, sector, selectively, significance, singularly, sporadic, statistical, Subtopic, surface, Temple, tolerated, transition, trend, undelivered, undergoing, unexpected, weaned, Welfare, workforce
Filing tables
Filing exhibits
- 10-K Annual report
- 12.1 Computation Ratio of Earnings Available to Cover Fixed Charges
- 21 List of Subsidiaries
- 23 Consent of Independent Registered Public Accounting Firm
- 31 Certification of Chief Executive Officer Pursuant to Section 302
- 31 Certification of Chief Financial Officer Pursuant to Section 302
- 32 Certification of Annual Financial Report by the Chief Executive Officer and Chief Financial Officer Furnished Pursuant to Section 906
- PDF 10-K
- 12.1 Computation Ratio of Earnings Available to Cover Fixed Charges
- 21 List of Subsidiaries
- 23 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer Pursuant to Section 302
- 31.2 Certification of Chief Financial Officer Pursuant to Section 302
- 32 Certification of Annual Financial Report by the Chief Executive Officer and Chief Financial Officer Furnished Pursuant to Section 906
Related press release
NPSP similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
NPS Pharmaceuticals, Inc.:
We consent to incorporation by reference in the registration statements (Nos. 333-79622, 333-17521, 333-94269, 333-124821, 333-126823, 333-159363, 333-168533, and 333-176012) on Form S-8 and (Nos. 333-146235, 333-159321, 333-169388, 333-170283, and 333-176006) on Form S-3 of NPS Pharmaceuticals, Inc. of our reports dated February 21, 2013, with respect to the consolidated balance sheets of NPS Pharmaceuticals, Inc. and subsidiaries as of December 31, 2012 and 2011, and the related consolidated statements of operations, comprehensive loss, stockholders' deficit, and cash flows for each of the years in the three-year period ended December 31, 2012, and the effectiveness of internal control over financial reporting as of December 31, 2012, which reports appear in the December 31, 2012 annual report on Form 10-K of NPS Pharmaceuticals, Inc.
/s/ KPMG LLP
Short Hills, New Jersey
February 21, 2013